EURETINA Satellite Education Programme - Barcelona 2017

17th EURETINA Congress 7 – 10 September 2017

Satellite Education Programme

Boxed Lunch Included

Thursday 13.00 – 14.00

Thursday 7 September

13.00 – 14.00 Room 111

Recent Advances in the Management of Retinal Disease Moderators: A. Loewenstein ISRAEL U. Chakravarthy UK

F. Behar-Cohen SWITZERLAND Inflammation beyond the surface Y.H. Yoon SOUTH KOREA OCT biomarkers, can we identify responders vs non-responders U. Chakravarthy UK The UK EMR study of DME: a test model for outcomes in real life A. Loewenstein ISRAEL Management of DME – clinical studies vs real life outcomes D. Zur ISRAEL “The International Retina Group Project” a multicentre study

Sponsored by

Lunchtime

P. Udaondo SPAIN Ozurdex® (dexamethasone) in clinical practice

Thursday 13.00 – 14.00

Thursday 7 September

Boxed Lunch Included

13.00 – 14.00 Room 113

Swept Source OCT & Angiography: Clinical Advances and Applications

Moderator: L. Arias SPAIN L. Arias SPAIN Clinical decisions for the management of wet AMD patients based on multimodal imaging without dye injection A. Adan SPAIN Utility of Swept Source OCT angio and OCT en-face for the management of posterior uveitis G. Anastassiou GERMANY Choroidal tumors with Swept Source OCT

Lunchtime

J. Ruiz-Moreno SPAIN Atrophy AMD quantification: accuracy of the automatic measurement of the area and perimeter

Sponsored by

Boxed Lunch Included

Thursday 13.00 – 14.00

Thursday 7 September

13.00 – 14.00 Room 114

Retinal Imaging – Pushing the Limits

G. Lang GERMANY AngioPlex OCT-A G. Staurenghi ITALY Widefield and ultrawidefield imaging J-F. Korobelnik FRANCE Multi-modal retinal imaging

Lunchtime

Sponsored by

Friday 10.00 – 11.00

Friday 8 September

10.00 – 11.00 Room 111

Aflibercept: Innovative Data and Emerging Evidence

Moderator: M.S. Figueroa SPAIN M.S. Figueroa SPAIN Welcome and Introductions F. Behar-Cohen SWITZERLAND Aflibercept and the role of a multi-target approach to retinal disease L. Clark USA Innovative imaging and functional outcomes with aflibercept G. Cheung SINGAPORE Emerging clinical evidence with aflibercept

Morning

M.S. Figueroa SPAIN Symposium summary and Q&A session

Sponsored by

Boxed Lunch Included

Friday 13.00 – 14.00

Friday 8 September

13.00 – 14.00 Room 116

Continuous Microdosing with ILUVIEN®: Real-world Optimisation of the Treatment of Chronic DME Moderators: H. Hoerauf GERMANY B. Corcóstegui SPAIN

H. Hoerauf GERMANY The evolution of clinical management of DME. What can ILUVIEN® offer?

A. Loewenstein ISRAEL Consider the alternative? It’s not all about anti-VEGF F. Goñi SPAIN Steroids and safety. How big is the elephant in the room?

B. Pessoa PORTUGAL Clinical experience and insights with ILUVIEN®

Sponsored by

Lunchtime

B. Corcóstegui SPAIN Implications for clinical practice. Summary and Q&A

Friday 13.00 – 14.00

Friday 8 September

Boxed Lunch Included

13.00 – 14.00 Room 111

Real World Evidence: Considerations for the Ophthalmologist Moderator: T.Y. Wong SINGAPORE T.Y. Wong SINGAPORE Welcome and introductions A. Cohen UK Real-world evidence: a valuable resource R. Tadayoni FRANCE Aflibercept in the real world: the latest evidence from clinical practice P. Kaiser USA Focusing on the patient: what to expect from RWE

Lunchtime

T.Y. Wong SINGAPORE Symposium summary and Q&A session

Sponsored by

Boxed Lunch Included

Friay 13.00 – 14.00

Friday 8 September

13.00 – 14.00 Room 117

Managing Retinal Diseases with Ranibizumab: New Evidence Moderator: J. Monés SPAIN J. Monés SPAIN Welcome and Introduction U. Chakravarthy UK Ranibizumab for retinal diseases: the journey so far F. Holz GERMANY Informing retreatment strategies through relevant endpoints A. Koh SINGAPORE Optimizing ranibizumab treatment: clinical data and case discussion Q&A

Lunchtime

Sponsored by

Friday 13.00 – 14.00

Friday 8 September

13.00 – 14.00 Room 113

High-End Imaging Today

Moderator: C. Mody UK E. Souied FRANCE Multimodal imaging of fibrosis T. Peto UK Why MultiColor SLO imaging is a must-have G. Staurenghi ITALY How to read OCTA images

Lunchtime

R. Gallego-Pinazo SPAIN OCTA live cases

Sponsored by

Boxed Lunch Included

Boxed Lunch Included

Friday 13.00 – 14.00

Friday 8 September

13.00 – 14.00 Room 114

Utilising Ultra-Widefield Retinal Imaging Clinical Applications and Practice Efficiency Moderator: P. Stanga UK P. Stanga UK Ultra-widefield imaging in the diagnosis and management of paediatric retinal diseases E. Souied FRANCE Using true ultra-widefield imaging for evaluating sickle cell retinopathy A. Joussen GERMANY Peripheral retinal ischaemia S. Sivaprasad UK Measure of non-perfusion on ultra-widefield imaging

Sponsored by

Lunchtime

S. Sadda USA Re-engineering the classification & staging of diabetic retinopathy: implications from ultra-widefield imaging

Friday 13.00 – 14.00

Friday 8 September

Boxed Lunch Included

13.00 – 14.00 Room 115

New Views on the Retina with Multimodal Imaging: Correlating Structure, Function and Retinal Sensitivity Moderator: S. Rizzo ITALY R. Abreu-Gonzalez SPAIN RS-3000 OCT and wide field OCT-A image D. Bacherini ITALY Integrated evaluation of vitreoretinal interface disorders: OCT angiography + microperimetry

Lunchtime

M. Nagpal INDIA Going deeper and wider with OCT angiography

Sponsored by

Boxed Lunch Included

Friday 13.00 – 14.00

Friday 8 September

13.00 – 14.00 Room 118

Nutrition & AMD: From Diagnosis to Treatment

Moderators: A. García Layana SPAIN A.M. Minella ITALY

C. Delcourt FRANCE S.T.A.R.S questionnaire: for an easy and fast identification of patient at risk of AMD A.M. Minnella ITALY, G. Garhofer AUSTRIA Early supplementation for AMD prevention & treatment - Pros/Cons A. García Layana SPAIN Latest scientific data on vitamin D & AMD. New pre-clinical data J. Seddon USA Latest scientific data on vitamin D & AMD. Recent clinical data

Sponsored by

Lunchtime

H. Bond UK How to advise patients on nutrition for AMD prevention

Saturday 10.00 – 11.00

Saturday 9 September

10.00 – 11.00 Room 111

Advanced Technologies Designed to See More and Do More Moderator: R. Tadayoni FRANCE K. Sabti KUWAIT Enhanced depth of field: every time in focus S. Rizzo ITALY Ultimate high magnification: concentrate on the details R. Tadayoni FRANCE Improved peripheral acuity: broaden the retina view M.S. Figueroa SPAIN Explore the color channels: visualize the different structures of the eye

Morning

A. Couturier FRANCE NGENUITY a new standard of education

Sponsored by

Saturday 10.00 – 11.00

Saturday 9 September

10.00 – 11.00 Forum Auditorium

Advances in DME Treatment

Moderator: A. Loewenstein ISRAEL A. Loewenstein ISRAEL Welcome and introductions A. Tufail UK Challenges and innovations in diabetic retinopathy screening A. Loewenstein ISRAEL The importance of vision gains: a patient perspective N. Bressler USA Improving vision for patients: insights from the DRCR.net P. Kaiser USA Aflibercept: proactive treatment for long-term outcomes A. Loewenstein ISRAEL Symposium summary and Q&A session

Morning

Sponsored by

Saturday 10.00 – 11.00

Saturday 9 September

10.00 – 11.00 Room 117

New Perspectives in DME Management

Moderators: B. Kuppermann USA M. de Smet SWITZERLAND

J. Zarranz-Ventura SPAIN OCTA in DME – now and beyond now R. Raman INDIA Cytokines in DR and DME M. de Smet SWITZERLAND Predicting retina disease B. Kuppermann USA, M. Gillies AUSTRALIA Debate: early intervention with corticosteroids in DME? Yes/No

Morning

L. Kodjikian FRANCE Ozurdex® (dexamethasone) in real life

Sponsored by

Saturday 10.00 – 11.00

Saturday 9 September

10.00 – 11.00 Room 118

IRIDEX MicroPulse® Laser in Vascular Macular Disease Moderator: S. Vujosevic ITALY M. Zarbin USA The science, benefits & utility of MicroPulse S. Vujosevic ITALY MicroPulse laser therapy in DME: morphologic and functional safety and efficacy M. Escaf COLOMBIA TxCell™- Guided MicroPulse: safe, effective & immediate care for CSR patients

Morning

Sponsored by

Saturday 13.00 – 14.00

Saturday 9 September

Boxed Lunch Included

13.00 – 14.00 Room 120

A New Chapter in Retina Surgery with Bausch + Lomb

Moderator: S. Rizzo ITALY M. Amon AUSTRIA The Stellaris® PC - latest illumination and laser technology I. Jürgens SPAIN Experience with the Stellaris® PC in combined surgery C. Awh USA The next chapter for the Stellaris® platform - introducing the hypersonic vitrectomy technology

Lunchtime

P. Stanga UK First clinical experience in human eyes with the Vitesse™ hypersonic vitrectomy device

Sponsored by

Boxed Lunch Included

Saturday 13.00 – 14.00

Saturday 9 September

13.00 – 14.00 Room 111

Ranibizumab for nAMD: New Evidence to Improve Patient Care

Moderator: M.S. Figueroa SPAIN M.S. Figueroa SPAIN Welcome and introduction A. Loewenstein ISRAEL Navigating the evidence base of ranibizumab for nAMD P. Mitchell AUSTRALIA Leveraging real-world data to address current challenges in practice R. Tadayoni FRANCE Treat and extend: efficacy without burden Case discussion followed by Q&A

Lunchtime

Sponsored by

Saturday 13.00 – 14.00

Saturday 9 September

Boxed Lunch Included

13.00 – 14.00 Room 118

Can Innovation in Small Gauge Surgery Enhance Patient Outcomes Without Compromising Surgeon Control?

Moderator: P. Stalmans BELGIUM M. Romano ITALY Why fluidics should influence your choice of vitrectome M. Vecchi ITALY Can you rely on your VR machine in complicated cases?

M. Ruiz SPAIN Why is PFCL safety paramount?

Lunchtime

M. Pavlidis GERMANY 27G limitations & solutions

Sponsored by

Boxed Lunch Included

Saturday 13.00 – 14.00

Saturday 9 September

13.00 – 14.00 Room 117

Impact of Geographic Atrophy: Enhancing Our Understanding of the Disease

Moderator: J. Monés SPAIN J. Monés SPAIN Welcome and introduction R. Tadayoni FRANCE Diagnostic paradigms of geographic atrophy N. Bressler USA Measuring disease-specific functional outcomes F. Holz GERMANY Geographic atrophy: a progressive disease U. Chakravarthy UK Characterizing disease burden using real-world data

Sponsored by

Lunchtime

Q&A

EURETINA Satellite Meetings Floorplan

127 128 124

123 Wetlabs 122

LEVEL M2

129 130 Speaker Check-In 133

120

134

118

111

114

113

115 116

LEVEL 1

117

LEVEL M1 EN

TR AN

CE

EXHIBITION HALL

LEVEL 0

N

TIO RA ST I G RE

CE

EN

AN TR

B

FORUM AUDITORIUM

A